Skip to main
  1. Stocks
  2. Lakewood-Amedex Biotherapeutics Inc
  3. Earnings
LABT

LABT Earnings Dates & Reports

LABT Most Recent Earnings

Report Date
Period EndingQ3 2026
Est. EPS-$1.17
Actual EPS-$0.62
EarningsBeat

LABT Earnings

View the latest LABT earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.

Start investing in LABT

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LABT Earnings per Share (EPS) History

Signup for full access
Browse free

LABT Latest Earnings

The value each LABT share was expected to gain vs. the value each share gained.

LABT reported its most recent earnings on for Q3 2026, posting earnings per share (EPS) of -$0.62. This exceeded analysts' expectations of -$1.17 by 47.01%, marking a Beat.

For comparison, Lakewood-Amedex Biotherapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.24.

LABT Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2026
-$0.24
Q3 2026
-$1.17-$0.62-47.01%
Q2 2026
–-$2.75—

LABT Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Lakewood-Amedex Biotherapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
———
———

LABT Earnings FAQs

LABT last reported earnings on Nov 16, 2026 for Q3 2026, posting an EPS of -$0.62, which Beat the estimate of -$1.17 by 47.01%.

For Q3 2026, LABT reported an EPS of -$0.62, exceeding analysts' estimate of -$1.17 by 47.01%.

For Q3 2026, LABT Beat expectations with an actual EPS of -$0.62 vs. an estimated EPS of -$1.17.

Following the last earnings report on Nov 16, 2026, LABT's stock price moved — from — to —.

The next LABT earnings call is scheduled for Feb. 18, 2027, where executives will discuss financial results and outlook.

Lakewood-Amedex Biotherapeutics Inc (LABT)


LABT Earnings

View the latest LABT earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.

Start investing in LABT

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover LABT stock data and trends